What it actually is
HGH Frag 176-191 is the C-terminal fat-loss fragment of growth hormone.
It aims to burn fat without raising IGF-1 or blood sugar like real GH. AOD-9604 is the same fragment with a tyrosine swapped in at the front (Tyr-hGH 177-191), so the two are near-identical.
How it’s thought to work
- Lipolysis — stimulates fat breakdown, mimicking GH’s fat-metabolism region.
- Reduced lipogenesis — blocks new fat storage.
- No IGF-1/glucose spike — in theory, avoids GH’s growth/sugar effects.
- Fasted-dependent — food/insulin blunts the effect.
What the research says
Not approved for anything. Its cousin AOD-9604 was tested as a weight-loss pill: a 12-week trial reported a small edge (2.6 kg vs 0.8 kg on placebo), then a 536-person, 24-week trial found no significant weight loss and development stopped in 2007 — so the fat-loss effect is largely anecdotal.
- Targeted fat metabolism (anecdotal).
- No IGF-1/glucose effect (in theory).
- Often stacked with a GHRH.
Watch: HGH Frag 176-191 explained
Video by More Plates More Dates on YouTube. Not affiliated with Peptide Carl and not an endorsement — included because a second explanation of the same mechanism is often what makes it click.
Reported protocols
These are the doses the peptide community actually reports running (Reddit & forums), alongside published research — logged for education, not as a recommendation to use.
| Parameter | Commonly reported range |
|---|---|
| Community dose | 250–500 mcg per dose (250 mcg once daily, or split AM/PM) |
| Frequency | 1–2× daily, always fasted |
| Route | SubQ |
| Cycle | ~4 weeks on, then a washout; often stacked with a GHRH |
| Community tip | Fasted timing is non-negotiable — eat near the dose and you kill the fat-burning effect |
Common use cases
| Goal | Community protocol notes |
|---|---|
| Fat loss | 250 mcg fasted 1–2×/day, ~4 wks + washout |
| Stacked with a GHRH | for synergy vs run solo |
| (Reality) | closest human evidence (AOD) failed vs placebo |
Mixing it (reconstitution)
Freeze-dried peptides must be reconstituted with bacteriostatic water before they can be measured. Carl’s calculator turns “mg in the vial + ml of water + target dose” into “units on the syringe” — and tells you how long the vial lasts.
→ Open the Reconstitution Calculator
Injection & handling
SubQ, 250–500 mcg, always on an empty stomach (AM fasted and/or a couple hours after the last meal). Refrigerate reconstituted, use within ~28 days.
Stacks it appears in
- Fat-loss GH combo — HGH Frag + Tesamorelin / CJC-Ipa — the fragment plus a GHRH.
Sources
- UniProt P01241: human growth hormone sequence
- Detection and metabolism of AOD9604, Drug Test Anal 2015 (PMID 25208511)
- Antilipogenic action of hGH 177-191, Biochem Mol Biol Int 1993 (PMID 8358331)
- Metabolic studies of AOD9604 in obese rats, Horm Res 2000 (PMID 11146367)
- hGH and its C-terminal fragment in obese mice, Int J Obes 2001 (PMID 11673763)
- AOD9604 human safety summary (6 RCTs), J Endocrinol Metab 2013 (doi 10.4021/jem157w)
- AOD9604 24-week weight-loss trial (OPTIONS), ANZCTR ACTRN12605000067673
- FDA compounding safety list (Category 2), Apr 2026
- AOD-9604 trials reviewed, Misra 2013, Curr Cardiol Rev (PMID 23092275)

Carl read the papers